These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 31213067)

  • 1. Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer's Disease Progression.
    Findley CA; Bartke A; Hascup KN; Hascup ER
    ASN Neuro; 2019; 11():1759091419855541. PubMed ID: 31213067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease.
    Jürgensen S; Ferreira ST
    J Mol Neurosci; 2010 Jan; 40(1-2):221-9. PubMed ID: 19690986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease amyloid beta-protein and synaptic function.
    Ondrejcak T; Klyubin I; Hu NW; Barry AE; Cullen WK; Rowan MJ
    Neuromolecular Med; 2010 Mar; 12(1):13-26. PubMed ID: 19757208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.
    Parri HR; Hernandez CM; Dineley KT
    Biochem Pharmacol; 2011 Oct; 82(8):931-42. PubMed ID: 21763291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To think or not to think: synaptic activity and Abeta release.
    Schroeder BE; Koo EH
    Neuron; 2005 Dec; 48(6):873-5. PubMed ID: 16364890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid beta peptides and glutamatergic synaptic dysregulation.
    Parameshwaran K; Dhanasekaran M; Suppiramaniam V
    Exp Neurol; 2008 Mar; 210(1):7-13. PubMed ID: 18053990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease drug discovery: Abeta and beyond.
    Shineman DW; Fillit HM
    Curr Alzheimer Res; 2010 May; 7(3):188-9. PubMed ID: 20406195
    [No Abstract]   [Full Text] [Related]  

  • 10. Synaptic dysfunction in Alzheimer's disease.
    Marcello E; Epis R; Saraceno C; Di Luca M
    Adv Exp Med Biol; 2012; 970():573-601. PubMed ID: 22351073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
    Nimmrich V; Ebert U
    Rev Neurosci; 2009; 20(1):1-12. PubMed ID: 19526730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease.
    Paula-Lima AC; Brito-Moreira J; Ferreira ST
    J Neurochem; 2013 Jul; 126(2):191-202. PubMed ID: 23668663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.
    Danysz W; Parsons CG
    Br J Pharmacol; 2012 Sep; 167(2):324-52. PubMed ID: 22646481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities.
    Li S; Stern AM
    Mol Psychiatry; 2022 Aug; 27(8):3182-3191. PubMed ID: 35484241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease.
    Ma KG; Qian YH
    Neuropeptides; 2019 Feb; 73():96-106. PubMed ID: 30579679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairments of glutamatergic synaptic transmission in Alzheimer's disease.
    Zott B; Konnerth A
    Semin Cell Dev Biol; 2023 Apr; 139():24-34. PubMed ID: 35337739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells.
    Guan ZZ; Miao H; Tian JY; Unger C; Nordberg A; Zhang X
    J Neural Transm (Vienna); 2001; 108(12):1417-33. PubMed ID: 11810405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered neurotransmission prior to cognitive decline in AβPP/PS1 mice, a model of Alzheimer's disease.
    Hascup KN; Hascup ER
    J Alzheimers Dis; 2015; 44(3):771-6. PubMed ID: 25374106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.
    Almeida CG; Tampellini D; Takahashi RH; Greengard P; Lin MT; Snyder EM; Gouras GK
    Neurobiol Dis; 2005 Nov; 20(2):187-98. PubMed ID: 16242627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.